NSE:NIVABUPA management interview: Strong Q4 For Niva Bupa Health | GST Cut Has Provided Strong Tailwinds, Says Company | CNBC TV18
CNBC-TV18, 2026-05-11. Video: https://www.youtube.com/watch?v=D5lUwxDET9U
- Quarterly performance drivers: Strong Q4 results, including net profit growth of over 60%, were driven by sustained multi-channel distribution, product innovation, and technology investments alongside GST tailwinds in Q3 and Q4.
- Long-term growth guidance: The company expects the retail segment to expand by 17–18% and aims to grow 5–8 percentage points faster than the market, targeting a 5-year CAGR of 23–25%.
- Combined ratio targets: Under Ind AS, Niva Bupa targets bringing its combined ratio down from 101.4% to 98–99% by FY29 to achieve a mid-to-high teens return on equity. Operating leverage from lower renewal book costs and AI-driven expense management will serve as the primary drivers.
- Regulatory reform outlook: Management considers the single limit on expense of management to be a transformational reform that should continue, anticipating that upcoming distribution regulations will be introduced gradually and without industry disruption.